BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 20044862)

  • 1. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for bacterial vaginosis in patients at high risk of preterm labor and premature rupture of membranes.
    Darwish A; Elnshar EM; Hamadeh SM; Makarem MH
    J Obstet Gynaecol Res; 2007 Dec; 33(6):781-7. PubMed ID: 18001442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
    Bradshaw CS; Vodstrcil LA; Hocking JS; Law M; Pirotta M; Garland SM; De Guingand D; Morton AN; Fairley CK
    Clin Infect Dis; 2013 Mar; 56(6):777-86. PubMed ID: 23243173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on vaginal or oral treatment of bacterial vaginosis.
    Mikamo H; Kawazoe K; Izumi K; Watanabe K; Ueno K; Tamaya T
    Chemotherapy; 1997; 43(1):60-8. PubMed ID: 8996744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Steinmetz JI; Schumacher RJ; Joffrion JL
    Sex Transm Dis; 2007 Apr; 34(4):197-202. PubMed ID: 17179772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of clindamycin vaginal ovule (3-day treatment) vs. clindamycin vaginal cream (7-day treatment) in bacterial vaginosis.
    Sobel J; Peipert JF; McGregor JA; Livengood C; Martin M; Robbins J; Wajszczuk CP
    Infect Dis Obstet Gynecol; 2001; 9(1):9-15. PubMed ID: 11368263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis.
    Fischbach F; Petersen EE; Weissenbacher ER; Martius J; Hosmann J; Mayer H
    Obstet Gynecol; 1993 Sep; 82(3):405-10. PubMed ID: 8355942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
    Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
    Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
    BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of a single dose of polyhexamethylene biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis.
    Minozzi M; Gerli S; Di Renzo GC; Papaleo E; Ferrari A
    Eur Rev Med Pharmacol Sci; 2008; 12(1):59-65. PubMed ID: 18401974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach for the treatment of bacterial vaginosis: use of polyhexamethylene biguanide. A prospective, randomized study.
    Gerli S; Rossetti D; Di Renzo GC
    Eur Rev Med Pharmacol Sci; 2003; 7(5):127-30. PubMed ID: 15214587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole.
    Schmitt C; Sobel JD; Meriwether C
    Obstet Gynecol; 1992 Jun; 79(6):1020-3. PubMed ID: 1579299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial.
    Andres FJ; Parker R; Hosein I; Benrubi GI
    South Med J; 1992 Nov; 85(11):1077-80. PubMed ID: 1439943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety.
    Weissenbacher ER; Donders G; Unzeitig V; Martinez de Tejada B; Gerber S; Halaška M; Špaček J;
    Gynecol Obstet Invest; 2012; 73(1):8-15. PubMed ID: 22205034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
    Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
    mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New alternatives in the treatment of bacterial vaginosis].
    Luis Arredondo J; Higuera F; Narcio ML; Casanova G; Beltrán M
    Ginecol Obstet Mex; 1994 Aug; 62():226-34. PubMed ID: 7959144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.